MSX-130 is an antagonist of C-X-C chemokine receptor type 4 (CXCR4).

 

Brand: BCM

 

Target: CXCR

 

Signaling Pathways: Autophagy; GPCR/G Protein; Immunology/Inflammation

 

Solubility: Soluble in DMSO. Insoluble in Water; Insoluble in Ethanol.

 

GHS: GHS07

 

Isomeric SMILES: C1=CC=C(C=C1)C2=C(N=C(N2)C3=CC=C(C=C3)C4=NC(=C(N4)C5=CC=CC=C5)C6=CC=CC=C6)C7=CC=CC=C7  

 

InChIKey: MKRQQXYFSWSAIS-UHFFFAOYSA-N  

 

InChI: InChI=1S/C36H26N4/c1-5-13-25(14-6-1)31-32(26-15-7-2-8-16-26)38-35(37-31)29-21-23-30(24-22-29)36-39-33(27-17-9-3-10-18-27)34(40-36)28-19-11-4-12-20-28/h1-24H,(H,37,38)(H,39,40)

 

Attribute
[Chem Name]	2-[4-(4,5-diphenyl-1H-imidazol-2-yl)phenyl]-4,5-diphenyl-1H-imidazole
[Synonym]	MSX-130
[CAS No.]	4051-59-6
[MDL No.]	MFCD00231029
[Formula]	C36H26N4
[Molecular]	514.62
[Form]	Solid Powder
[Storage]	Sealed in dry, 2-8°C

Goods Tag